Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary Syndromes

Circulation - United States
doi 10.1161/hc0302.102573
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Ovid Technologies (Wolters Kluwer Health)